Global House Dust Mite Allergy Market Dynamics, and Growth Analysis 2024-2033 By Top Leading Players | Allergy Therapeutics PLC, Bayer AG, Catalent Inc., GSK PLC, Merz Pharma GmbH & Co KGaA.

Spread the love

The House Dust Mite Allergy  by The Business Research Company provides market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2024-2033).

Learn More On The House Dust Mite Allergy  Market:
https://www.thebusinessresearchcompany.com/report/house-dust-mite-allergy-global-market-report

The House Dust Mite Allergy market has witnessed substantial growth in recent years, with projections indicating further expansion. According to The Business Research Company, the market size surged from $1.9 billion in 2024 to $2.18 billion in 2024, boasting a notable compound annual growth rate (CAGR) of 14.9%. This upward trajectory stems from heightened awareness initiatives, improved diagnostic technologies, extensive research endeavors, bolstered healthcare infrastructure, and adherence to regulatory frameworks.

Forecasts indicate a robust upward trend, with the market expected to reach $3.69 billion by 2028, exhibiting a CAGR of 14.0%. Anticipated drivers of this growth include enhanced regulatory backing, heightened prevalence of allergies, the proliferation of telemedicine and remote care services, and an increased emphasis on precision medicine. Moreover, notable trends such as intensified public health campaigns, the integration of digital health solutions, a focus on indoor environmental quality, the expansion of immunotherapy options, and advancements in allergen avoidance products are poised to reshape the landscape.

The prevalence of asthma diseases is expected to propel the growth of the house dust mite allergy market going forward. Asthma refers to a disease that causes one’s airways to constrict, swell and occasionally create more mucus that affects the lungs creating breathing issues. The patients suffering from asthma could easily affect by the surrounding dust which makes them more allergic and would increase their disease condition and need of several anti-allergic drugs, as a result, the increasing prevalence of asthma diseases increases the demand for house dust mite allergy treatments. For instance, in October 2021, according to the London School of Hygiene and Tropical medicine, an England-based public university, the prevalence of asthma increased by about more than 2% in Africa and 1 % every 10 years in Europe. Furthermore, in April 2024, according to Asthma + Lung UK, a UK-based non-profit organization defending the freedom to breathe, between 2021 and 2022, hospital admissions for children with Asthma surged by 149 percent in England and Wales.  Therefore, the prevalence of asthma diseases is driving the house dust mite allergy market.

Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample.aspx?id=9304&type=smp

The house dust mite allergy market covered in this report is segmented –
1) By Product Type: Tablets, Nasal Drops, Injectable
2) By Treatment Type: Medication, Immunotherapy, Nasal Irrigation, Other Types
3) By Diagnosis: Skin Prick Test (SPT), Specific Immunoglobulin E (IgE) Blood Test, Other Diagnosis
4) By Dosage Forms: Solid, Liquid
5) By End Users: Hospitals, Homecare, Specialty Clinics, Other End Users

Top 5 Major Players:

Key players in the House Dust Mite Allergy market are channeling efforts towards pioneering anti-allergy medications to fortify their market standing. These medications, designed to mitigate or prevent allergy symptoms, represent a crucial frontier in healthcare innovation. Notably, Bausch + Lomb, a prominent Canadian eye health products company, introduced the Alaway Preservative Free antihistamine eye drops in February 2021. These drops, the first FDA-approved over-the-counter preservative-free antihistamine eye itch relief solution, cater to the needs of approximately 80% of allergy sufferers experiencing ocular discomfort, particularly during peak allergy seasons. Leveraging a potent prescription-strength formula, Alaway Preservative Free effectively blocks histamine release and alleviates allergic inflammation, ensuring rapid and enduring relief for up to 12 hours with a single dose. This groundbreaking development signifies a significant stride in addressing ocular itch symptoms among allergy sufferers, promising enhanced therapeutic outcomes and improved quality of life.

The house dust mite allergy  market report table of contents includes:
1. Executive Summary
2. House Dust Mite Allergy Market Characteristics
3. House Dust Mite Allergy Market Trends And Strategies
4. House Dust Mite Allergy Market – Macro Economic Scenario
5. Global House Dust Mite Allergy Market Size and Growth

….

31. Global House Dust Mite Allergy Market Competitive Benchmarking
32. Global House Dust Mite Allergy Market Competitive Dashboard
33. Key Mergers And Acquisitions In The House Dust Mite Allergy Market
34. House Dust Mite Allergy Market Future Outlook and Potential Analysis
35. Appendix

List of Tables:
Table 1: Global Historic Market Growth, 2018-2023, $ Billion
Table 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
Table 3: Global House Dust Mite Allergy Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 4: Global House Dust Mite Allergy Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 5: Global House Dust Mite Allergy Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

….

Table 76: Allergy Therapeutics Plc Financial Performance
Table 77: Bayer AG Financial Performance
Table 78: Catalent Inc. Financial Performance
Table 79: GSK Plc Financial Performance
Table 80: Merz Pharma GmbH & Co KGaA Financial Performance

Related Reports:
https://topprnews.com/sustainability-and-energy-management-software-market-analysis/
https://topprnews.com/swine-vaccines-market-share/
https://topprnews.com/synthetic-latex-polymers-market-share/
https://goodprnews.com/sustainability-and-energy-management-software-market-analysis/
https://goodprnews.com/swine-vaccines-market-share/
https://goodprnews.com/synthetic-latex-polymers-market-share/

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model


Spread the love

About Top PR News

TopPRnews Leads Drives Search Engine Visibility For Your Press Release Content. Our Global Network Reaches Important Contacts, Media Partners And Websites And Journalists. Happy Postings! If You Have Any Queries Please Contact Official Mail At [[email protected]}

View all posts by Top PR News →